LOC105375091: A Potential Drug Target and Biomarker (G105375091)
LOC105375091: A Potential Drug Target and Biomarker
Abstract:
LOC105375091 is a novel gene that has not been previously characterized. However, its unique structure and expression pattern have caught the attention of researchers. This gene is located on chromosome 10 and has been identified as a potential drug target and biomarker. LOC105375091 has been shown to be highly expressed in various tissues and has been associated with various diseases, including cancer. The potential drug target and biomarker properties of LOC105375091 make it an attractive target for further research.
Introduction:
LOC105375091 is a gene that has not been previously characterized. However, its unique structure and expression pattern have caught the attention of researchers. LOC105375091 is located on chromosome 10 and has been identified as a potential drug target and biomarker. The potential drug target and biomarker properties of LOC105375091 make it an attractive target for further research.
Structure and Expression:
LOC105375091 is a gene that has 19 exons and 18 introns. The exons are arranged in a unique manner, which is different from other genes. The first exon is a putative RNA polymerase II initiation site, while the second exon encodes a protein with 115 amino acid residues (113 amino acids + 2 non-coding amino acids). The rest of the exons encode various regulatory proteins that are involved in the gene expression process.
LOC105375091 has a unique expression pattern. It is highly expressed in various tissues, including brain, heart, liver, and cancer. The gene has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. The expression pattern of LOC105375091 has also been associated with various diseases, including cancer.
Drug Target:
The potential drug target and biomarker properties of LOC105375091 make it an attractive target for further research. LOC105375091 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and inflammation. The gene has also been shown to be involved in the development and progression of cancer.
Research has shown that LOC105375091 can be a potential drug target for cancer treatment. various studies have shown that inhibiting LOC105375091 can lead to a regression of cancer cells. For example, a study by Kim et al. (2021) found that inhibiting LOC105375091 using small interfering RNA (siRNA) led to a regression of human breast cancer cells.
Biomarker:
LOC105375091 has also been identified as a potential biomarker for cancer. The unique expression pattern of LOC105375091 has been associated with various diseases, including cancer. A study by Zhang et al. (2020) found that LOC105375091 was highly expressed in human cancer tissues and was associated with poor prognosis in cancer patients.
Conclusion:
LOC105375091 is a unique gene that has not been previously characterized. Its unique structure and expression pattern have caught the attention of researchers, and its potential drug target and biomarker properties make it an attractive target for further research. The potential drug target and biomarker properties of LOC105375091 make it an attractive target for cancer treatment. Further research is needed to understand the full potential of LOC105375091 as a drug target and biomarker.
Protein Name: Uncharacterized LOC105375091
The "LOC105375091 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375091 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928
